First-Line Camizestrant for Emerging <i>ESR1</i> -Mutated Advanced Breast CancerFrançois‐Clément Bidard, Nicholas C. Turner, X. Cynthia et al.|New England Journal of Medicine|2025Cited by 106
Proof-of-concept study of a small language model chatbot for breast cancer decision support – a transparent, source-controlled, explainable and data-secure approachSebastian Griewing, Sebastian Kühn, Fabian Lechner et al.|Journal of Cancer Research and Clinical Oncology|2024Cited by 16